首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   97084篇
  免费   578篇
  国内免费   668篇
  98330篇
  2022年   34篇
  2021年   68篇
  2020年   38篇
  2019年   38篇
  2018年   11876篇
  2017年   10720篇
  2016年   7515篇
  2015年   707篇
  2014年   444篇
  2013年   522篇
  2012年   4468篇
  2011年   13072篇
  2010年   12155篇
  2009年   8352篇
  2008年   9966篇
  2007年   11568篇
  2006年   461篇
  2005年   724篇
  2004年   1146篇
  2003年   1222篇
  2002年   983篇
  2001年   326篇
  2000年   221篇
  1999年   93篇
  1998年   74篇
  1997年   69篇
  1996年   52篇
  1995年   43篇
  1994年   49篇
  1993年   58篇
  1992年   68篇
  1991年   77篇
  1990年   38篇
  1989年   48篇
  1988年   48篇
  1987年   40篇
  1986年   21篇
  1985年   26篇
  1984年   38篇
  1983年   31篇
  1982年   21篇
  1981年   17篇
  1979年   22篇
  1978年   20篇
  1976年   17篇
  1972年   258篇
  1971年   284篇
  1970年   16篇
  1965年   16篇
  1962年   25篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
132.
European beech (Fagus sylvatica L.) is one of the most important forest tree species in Central Europe. Climate change scenarios predict an increase in annual mean temperatures that may cause earlier bud burst in spring, potentially leading to an increased late frost-risk. Despite the ecologic and economic importance of beech, knowledge about the molecular basis of bud burst is still scarce in this species. Here, an association analysis was used to detect SNPs that are significantly associated with beech bud burst. A translocation experiment was established with progenies of six different beech populations from three widely separated regions in Northeast, Central, and Southwest Germany. In total, 600 individuals of the translocation experiment were genotyped using a set of 46 SNPs located in bud burst candidate genes. The association analysis revealed seven SNPs significantly associated with bud burst, each SNP explaining only a few percent of the observed phenotypic variation. Since the same SNP set was used in a previous association analysis with European beech, we were able to compare and confirm significant associations between SNPs and bud burst in distinct beech populations growing in different environments.  相似文献   
133.
We aim to investigate whether A2A/nitric oxide-mediated regulation of vascular endothelial growth factor (VEGF) expression is impaired in feto-placental endothelial cells from late-onset pre-eclampsia. Cultures of human umbilical vein endothelial cells (HUVECs) and human placental microvascular endothelial cells (hPMECs) from normal and pre-eclamptic pregnancies were used. Assays by using small interference RNA (siRNA) for A2A were performed, and transfected cells were used for estimation of messenger RNA (mRNA) levels of VEGF, as well as for cell proliferation and angiogenesis in vitro. CGS-21680 (A2A agonist, 24 h) increases HUVEC and hPMEC proliferation in a dose response manner. Furthermore, similar to CGS-21680, the nitric oxide donor, S-nitroso-N-acetyl-penicillamine oxide (SNAP), increased cell proliferation in a dose response manner (logEC50 10?9.2 M). In hPMEC, CGS-21680 increased VEGF protein levels in both normal (~1.5-fold) and pre-eclamptic pregnancies (~1.2-fold), an effect blocked by the A2A antagonist, ZM-241385 (10?5 M) and the inhibitor of NO synthase, N ω-nitro-L-arginine methyl ester hydrochloride (L-NAME). Subsequently, SNAP partially recovered cell proliferation and in vitro angiogenesis capacity of cells from normal pregnancies exposed to siRNA for A2A. CGS-21680 also increased (~1.5-fold) the level of VEGF mRNA in HUVEC from normal pregnancies, but not in pre-eclampsia. Additionally, transfection with siRNA for A2A decrease (~30 %) the level of mRNA for VEGF in normal pregnancy compared to untransfected cells, an effect partially reversed by co-incubation with SNAP. The A2A-NO-VEGF pathway is present in endothelium from microcirculation and macrocirculation in both normal and pre-eclamptic pregnancies. However, NO signaling pathway seems to be impaired in HUVEC from pre-eclampsia.  相似文献   
134.
Vascular dementia (VaD) is a degenerative cerebrovascular disorder that leads to progressive decline in cognitive abilities and memory. Several reports demonstrated that oxidative stress and endothelial dysfunction are principal pathogenic factors in VaD. The present study was constructed to determine the possible neuroprotective effects of simvastatin in comparison with cilostazol in VaD induced by l-methionine in rats. Male Wistar rats were divided into four groups. Group I (control group), group II received l-methionine (1.7 g/kg, p.o.) for 32 days. The remaining two groups received simvastatin (50 mg/kg, p.o.) and cilostazol (100 mg/kg, p.o.), respectively, for 32 days after induction of VaD by l-methionine. Subsequently, rats were tested for cognitive performance using Morris water maze test then sacrificed for biochemical and histopathological assays. l-methionine induced VaD reflected by alterations in rats’ behavior as well as the estimated neurotransmitters, acetylcholinesterase activity as well as increased brain oxidative stress and inflammation parallel to histopathological changes in brain tissue. Treatment of rats with simvastatin ameliorated l-methionine-induced behavioral, neurochemical, and histological changes in a manner comparable to cilostazol. Simvastatin may be regarded as a potential therapeutic strategy for the treatment of VaD. To the best of our knowledge, this is the first study to reveal the neuroprotective effects of simvastatin or cilostazol in l-methionine-induced VaD.
Graphical Abstract ?
  相似文献   
135.
136.
In recent years, the academic world has been faced with much academic misconduct. Examples involve plagiarizing papers, manipulating data, and launching predatory or hijacked journals. The literature exposing these activities is growing exponentially, and so is the presentation of criteria or guidelines for counteracting the problem. Most of the research is focused on predatory or hijacked journal detection and providing suitable warnings. Overlooked in all this is the fact that papers published in these journals are questionable, but nevertheless show up in standard citation databases. We need some way to flag them so future researchers will be aware of their questionable nature and prevent their use in literature review.  相似文献   
137.

Background

The purpose of this case series is to investigate the relationship between splenic thickness (ST) and postoperative outcomes after hepatic resection in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) patients.

Methods

The clinical data of 320 patients with HBV-associated HCC who had undergone liver resection were retrospectively analyzed. The value of ST in predicting postoperative outcomes was evaluated.

Results

A total of 320 patients were enrolled in the study. An increase in ST was significantly associated with an increase in portal vein diameter (PVD), indocyanine green retention rate 15 min (ICG R15), and total bilirubin (TBIL); however, it was negatively correlated with platelet count (PLT). Post-hepatectomy liver failure (PHLF) occurred in 35 (10.9%) patients. Multivariate logistic regression analysis showed that ST was an independent predictor of morbidity and mortality after hepatectomy. Meanwhile, ST was associated with an almost sixfold increased risk for developing perioperative complications (OR 5.678; 95% CI 2.873 to 11.224; P?<?0.001) and almost 13-fold increased risk for mortality after hepatectomy (OR 13.007; 95% CI 1.238 to 136.627; P?=?0.033).The area under the receiver operating characteristic (ROC) curve (AUC) of ST for predicting the incidence of PHLF was 0.754 (95% confidence interval (CI) 0.667 to 0.841; P?<?0.001), with a sensitivity of 57.1% and a specificity of 82.5%, which were significantly greater than those of the ICG R15 level (AUC 0.670; 95% CI 0.560 to 0.779; P?<?0.001). The critical value of ST was 43.5 mm.

Conclusions

ST, which is an easy, inexpensive, and routinely available perioperative marker, showed a favorable predictive value for postoperative outcomes in HBV-associated HCC patients.
  相似文献   
138.
139.
140.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号